Member Archive - Page 39 of 39

A. Start LAI ART in people with HIV (PWH) with detectable viremia if clinic attendance is expected to be high

B. Initiate LAI ART in PWH who are virologically suppressed on oral ART, who do not have known resistance to regimen components, and who have a plan for missed doses

C. Avoid LAI ART in PWH with prior ART failure, even if currently virologically suppressed

D. Require an oral lead-in for PWH to reduce injection reactions and prevent treatment failure

Professors

Kanecia Zimmerman, MD, MPH

Duke University

Associate Professor of Pediatrics

Durham, NC

Jason E. Zucker, MD

Columbia University

Assistant Professor of Medicine

New York, NY

March 10, 2026: Optimization of Long-Acting Injectable Antiretroviral Therapy